J Štěpán

Research interests

Publications

• Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society

  European Journal of Endocrinology · 2019 · https://doi.org/10.1530/eje-18-0736

• Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

  The Lancet Diabetes & Endocrinology · 2019 · https://doi.org/10.1016/s2213-8587(19)30346-8

• Teriparatide for osteoporosis: importance of the full course

  Osteoporosis International · 2016 · https://doi.org/10.1007/s00198-016-3534-6

• Osteoporosis in young adults: pathophysiology, diagnosis, and management

  Osteoporosis International · 2012 · https://doi.org/10.1007/s00198-012-2030-x

• A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

  Osteoporosis International · 2012 · https://doi.org/10.1007/s00198-012-1958-1

• Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

  Annals of the Rheumatic Diseases · 2005 · https://doi.org/10.1136/ard.2005.044958

• Sustained Vertebral Fracture Risk Reduction After Withdrawal of Teriparatide in Postmenopausal Women With Osteoporosis

  Archives of Internal Medicine · 2004 · https://doi.org/10.1001/archinte.164.18.2024

• Health-related quality of life and radiographic vertebral fracture

  Osteoporosis International · 2003 · https://doi.org/10.1007/s00198-003-1547-4

• Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS)

  Osteoporosis International · 2003 · https://doi.org/10.1007/s00198-002-1317-8

• Incidence of Limb Fracture across Europe: Results from the European Prospective Osteoporosis Study (EPOS)

  Osteoporosis International · 2002 · https://doi.org/10.1007/s001980200074

• Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

  Breast Cancer Research and Treatment · 2001 · https://doi.org/10.1023/a:1006478317173

• The Use of Biochemical Markers of Bone Turnover in Osteoporosis

  Osteoporosis International · 2000 · https://doi.org/10.1007/s001980070002

• Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

  Osteoporosis International · 1999 · https://doi.org/10.1007/pl00004171

• ASSESSMENT OF FRACTURE RISK AND ITS APPLICATION TO SCREENING FOR POSTMENOPAUSAL OSTEOPOROSIS

  Journal · 1994

• Castrated Men Exhibit Bone Loss: Effect of Calcitonin Treatment on Biochemical Indices of Bone Remodeling*

  The Journal of Clinical Endocrinology & Metabolism · 1989 · https://doi.org/10.1210/jcem-69-3-523

• Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women

  Bone · 1987 · https://doi.org/10.1016/8756-3282(87)90002-0

• Letter: Serum-alkaline-phosphatase during maintenance haemodialysis.

  PubMed · 1975

Current projects

No projects listed.